In this comprehensive presentation, Prof. Qi Tang shared the construction, organization, and future roadmap of the UTUC subspecialty team at Peking University First Hospital. The presentation highlighted the integration of multidisciplinary teams (surgery, medical oncology, radiotherapy, immunotherapy, and genetics) and their collaborative efforts in clinical research, including participation in international studies such as the 2025 EAU abstract on adjuvant radiotherapy combined with immunotherapy in high-risk UTUC.
Prof. Tang also emphasized the team’s expanding domestic and international collaborations, large-scale multicenter data integration, and efforts to establish one of the largest UTUC diagnosis and treatment centers in China.
